Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Tirzepatide and the risk of asthma exacerbations in patients with type 2 diabetes
Frontiers in endocrinology, 2026;17:1928877
Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management
Current pain and headache reports, 2026;30(1)
Exploring The Role of GLP-1 Receptor Agonists and DPP4 Inhibitors in the Treatment of Opioid Use Disorder: A Scoping Review
Journal of dual diagnosis, 2026;:1-14
GLP-1 receptor agonists and outcomes after cervical spine fusion: a systematic review, meta-analysis, and evidence map of real-world evidence
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026
Synthetic Versus Reference Semaglutide for Weight Management: Reporting Gaps and Clinical Claims
Diabetes, obesity & metabolism, 2026
Trends in Cost of Care With Tirzepatide in Adults Aged Over 55 Years With Obesity or Overweight Without Diabetes: A Matched Cohort Analysis
Diabetes, obesity & metabolism, 2026
Highlights from JAAD Reviews: Skin in the Game: Dermatologic and Medicolegal Aspects of GLP-1 Receptor Agonists
Journal of the American Academy of Dermatology, 2026
Dual-transporter-targeted oral nanomicelles of semaglutide enable enhanced intestinal absorption and metabolic reprogramming in obesity and diabetes
Journal of controlled release : official journal of the Controlled Release Society, 2026;:115297
Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy
Diabetes, obesity & metabolism, 2026
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs)
Naunyn-Schmiedeberg's archives of pharmacology, 2026
Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success
Nutrients, 2026;18(17)
Not Just for Diabetes: The Next Frontier for GLP-1 Agonists
Journal of the American Board of Family Medicine : JABFM;39(1)
A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders
Science advances, 2026;12(34):eaed3119
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study
Inflammatory bowel diseases, 2026
GLP-1 and GLP-1/GIP agonists in psoriasis: A real-world cohort study on healthcare resource usage
Journal of the European Academy of Dermatology and Venereology : JEADV, 2026
GLP-1 and dual GIP/GLP-1 receptor agonists’ psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation
Current psychiatry reports, 2026;28(1)
Effects of Incretin-Based Therapies on Testosterone Levels and Incretin Response in Men with Hypogonadism: A Systematic Literature Review Following PRISMA 2020 Guidelines
Pharmaceuticals (Basel, Switzerland), 2026;19(8)
Pharmacotherapy for Obstructive Sleep Apnea: From Pathophysiology to Emerging Treatments
Journal of clinical medicine, 2026;15(16)
Pharmacist-led medication therapy management improving medication adherence in a patient with type 2 diabetes: case report
Frontiers in medicine, 2026;13:1910565
Response to Comment on Klein et al. Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis
Diabetes care;49(9):e161-e162